(Updated - April 24, 2026 5:08 AM EDT)

Goldman Sachs analyst Corinne Johnson upgraded Altimmune (NASDAQ: ALT) from Sell ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Hot Comments Hot Upgrades Upgrades